Skip to main content
NCBI home page
Clinical and Experimental Immunology logoLink to Clinical and Experimental Immunology
. 1988 May;72(2):337–343.

Transient increase of serum IgD levels after allogeneic bone-marrow transplantation.

K Korver 1, J Radl 1, P T Schellekens 1, J M Vossen 1
PMCID: PMC1541531  PMID: 3044651

Abstract

Serum IgD levels were followed longitudinally twice a week for up to 100 days in 60 children undergoing allogeneic bone-marrow transplantation (n = 52) or immunosuppression (n = 8) for the treatment of leukaemia, severe aplastic anaemia or severe combined immunodeficiency. In 40 out of the 49 post-transplantation periods analysed (82%), a transient sharp increase of serum IgD was detected, irrespective of initial disease. A similar peak was found in one out of five children after immunosuppressive treatment. A second IgD peak was only recorded in grafted patients (14/49 post-transfusion periods). Peak levels of IgD ranged from 1.3 to 185.7 IU/ml (median 12.2 IU/ml), which represents a 2.6 to 22.4-fold increase over 'baseline' levels. In the transplanted leukaemia and aplastic anaemia patients, the rise of serum IgD occurred at the same time (geometric mean 16 days after transplantation) and was shown to represent heterogeneous polyclonal IgD in six of them. The onset of the serum IgD peak was significantly delayed in children suffering from severe combined immunodeficiency (P less than 0.05) and was demonstrated in one patient to consist of homogeneous IgD. No relation was found between either the occurrence of clinical acute graft-versus-host disease or infections after treatment, and the time of onset of IgD elevations. To detect transient serum IgD peaks as described here, frequent sampling of sera is necessary. The origin of the early IgD peaks seems to reside within the recipient's cells by an unknown mechanism. The late IgD peaks are most probably an expression of gradual reconstitution of the immune system following bone-marrow transplantation.

Full text

PDF
337

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BERKSON J., GAGE R. P. Calculation of survival rates for cancer. Proc Staff Meet Mayo Clin. 1950 May 24;25(11):270–286. [PubMed] [Google Scholar]
  2. Brandtzaeg P., Gjeruldsen S. T., Korsrud F., Baklien K., Berdal P., Ek J. The human secretory immune system shows striking heterogeneity with regard to involvement of J chain-positive IgD immunocytes. J Immunol. 1979 Feb;122(2):503–510. [PubMed] [Google Scholar]
  3. Buckley R. H., Fiscus S. A. Serum IgD and IgE concentrations in immunodeficiency diseases. J Clin Invest. 1975 Jan;55(1):157–165. doi: 10.1172/JCI107906. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Dicke K. A., van Bekkum D. W. Allogeneic bone marrow transplantation after elimination of immunocompetent cells by means of density gradient centrifugation. Transplant Proc. 1971 Mar;3(1):666–668. [PubMed] [Google Scholar]
  5. Josephs S. H., Buckley R. H. Serum IgD concentrations in normal infants, children, and adults and in patients with elevated IgE. J Pediatr. 1980 Mar;96(3 Pt 1):417–420. doi: 10.1016/s0022-3476(80)80684-6. [DOI] [PubMed] [Google Scholar]
  6. Kohler P. F., Farr R. S. Quantitative comparison of immunoglobulins in atopic (reaginic) and nonatopic (nonreaginic) individuals: higher gamma-D levels in atopic sera. J Allergy. 1967 May;39(5):311–322. doi: 10.1016/0021-8707(67)90095-0. [DOI] [PubMed] [Google Scholar]
  7. Korver K., Schellekens P. T., Dooren L. J., Vossen J. M. Transient elevation of serum IgE after allogeneic bone-marrow transplantation. Int Arch Allergy Appl Immunol. 1987;84(1):45–55. doi: 10.1159/000234397. [DOI] [PubMed] [Google Scholar]
  8. Lee E. T., Desu M. M. A computer program for comparing K samples with right-censored data. Comput Programs Biomed. 1972 Nov;2(4):315–321. doi: 10.1016/0010-468x(72)90019-0. [DOI] [PubMed] [Google Scholar]
  9. Luster M. I., Leslie G. A., Bardana E. J., Jr Structure and biological functions of human IgD. VI. Serum IgD in patients with allergic bronchopulmonary aspergillosis. Int Arch Allergy Appl Immunol. 1976;50(2):212–219. doi: 10.1159/000231498. [DOI] [PubMed] [Google Scholar]
  10. Okumura K., Tada T., Ochiai T. Effect of antithymocyte serum on reaginic antibody formation in the rat. Immunology. 1974 Feb;26(2):257–268. [PMC free article] [PubMed] [Google Scholar]
  11. Parkhouse R. M., Cooper M. D. A model for the differentiation of B lymphocytes with implications for the biological role of IgD. Immunol Rev. 1977;37:105–126. doi: 10.1111/j.1600-065x.1977.tb00247.x. [DOI] [PubMed] [Google Scholar]
  12. Rowe D. S., Anderson S. G., Tackett L. A research standard for human serum immunoglobulin D. Bull World Health Organ. 1970;43(4):607–609. [PMC free article] [PubMed] [Google Scholar]
  13. Rowe D. S., Hug K., Forni L., Pernis B. Immunoglobulin D as a lymphocyte receptor. J Exp Med. 1973 Oct 1;138(4):965–972. doi: 10.1084/jem.138.4.965. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Rádl J., Dooren L. J., Eijsvoogel V. P., van Went J. J., Hijmans W. An immunological study during post-transplantation follow-up of a case of severe combined immunodeficiency. Clin Exp Immunol. 1972 Feb;10(2):367–382. [PMC free article] [PubMed] [Google Scholar]
  15. Skvaril F., Rádl J. The fragmentation of human IgD during storage. Clin Chim Acta. 1967 Mar;15(3):544–546. doi: 10.1016/0009-8981(67)90023-x. [DOI] [PubMed] [Google Scholar]
  16. Storb R., Thomas E. D., Buckner C. D., Clift R. A., Johnson F. L., Fefer A., Glucksberg H., Giblett E. R., Lerner K. G., Neiman P. Allogeneic marrow grafting for treatment of aplastic anemia. Blood. 1974 Feb;43(2):157–180. [PubMed] [Google Scholar]
  17. Storb R., Thomas E. D., Weiden P. L., Buckner C. D., Clift R. A., Fefer A., Fernando L. P., Giblett E. R., Goodell B. W., Johnson F. L. Aplastic anemia treated by allogeneic bone marrow transplantation: a report on 49 new cases from Seattle. Blood. 1976 Dec;48(6):817–841. [PubMed] [Google Scholar]
  18. Thomas E., Storb R., Clift R. A., Fefer A., Johnson F. L., Neiman P. E., Lerner K. G., Glucksberg H., Buckner C. D. Bone-marrow transplantation (first of two parts). N Engl J Med. 1975 Apr 17;292(16):832–843. doi: 10.1056/NEJM197504172921605. [DOI] [PubMed] [Google Scholar]
  19. Vossen J. M., de Koning J., van Bekkum D. W., Dicke K. A., Eysvoogel V. P., Hijmans W., van Loghem E., Rádl J., van Rood J. J., van der Waay D. Successful treatment of an infant with severe combined immunodeficiency by transplantation of bone marrow cells from an uncle. Clin Exp Immunol. 1973 Jan;13(1):9–20. [PMC free article] [PubMed] [Google Scholar]
  20. White G. J., Holm M. S. Induction of reagin synthesis in the rat with associated and dissociated hemocyanin: effect of antilymphocyte serum. J Immunol. 1973 Feb;110(2):327–334. [PubMed] [Google Scholar]

Articles from Clinical and Experimental Immunology are provided here courtesy of British Society for Immunology

RESOURCES